retatrutide clinical trial south africa Eli Lilly infiltrates anti-obesity market as Phase III for begins Retatrutide Phase 3: TRIUMPH Program

"Obesity is a chronic disease, like high blood pressure," she explained, the kind of condition that often needs ongoing treatment to hold results steady, a view echoed in the American Diabetes Association's Standards of Care in Diabetes, 2026

Most so-called weight loss patches rely on herbal ingredients or stimulants with limited evidence showing they work, and they may not even be safe

And its important to remember that not everyone reaches or tolerates the maximum dose

Unlicensed peptides marketed for human weight loss are unlawful under the Human Medicines Regulations 2012, and the MHRA continues to remove illegal online listings and counterfeit semaglutide products [3][4][13]

We focus on identifying and treating the underlying medical and metabolic factors contributing to weight gain, including insulin resistance, PMOS (formerly PCOS), prediabetes, hormonal disorders, and obesity

These medications mimic natural GLP-1, a naturally occurring hormone produced by the body that plays a crucial role in how our bodies regulate blood sugar and appetite